Probiotic Supplementation With Bifidobacterium longum Subsp. Longum BL21 Improves Glycemic Control and Modulates Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial

Documenti analoghi

• Clinical Safety and Tolerability of Bifidobacterium bifidum BBi32: An 8‐Week Randomized, Double‐Blind, Placebo‐Controlled Trial With Genomic and In Vitro Corroboration
  di: Shuguang Fang, et al.
  Pubblicazione: (2026)
• A Novel Combination of Probiotic Supplements Reduces Gut Permeability, Oxidative Stress, and Inflammation in Undernourished Adults: A Randomized Controlled Trial
  di: Maryam Ahmadi‐Khorram, et al.
  Pubblicazione: (2026)
• Bifidobacterium longumBL‐19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine
  di: Xiajun Zhang, et al.
  Pubblicazione: (2024)
• Glycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications
  di: Yongjie Xu, et al.
  Pubblicazione: (2025)
• Curcumin/Turmeric Supplementation on Glycemic Control in Adults With Prediabetes and Type 2 Diabetes: A Systematic Review and Dose–Response Meta‐Analysis
  di: Hossein Bahari, et al.
  Pubblicazione: (2026)